INIS
reviews
100%
barriers
80%
hong kong
80%
netherlands
80%
levels
80%
comparative evaluations
80%
covid-19
80%
technology assessment
80%
cancer
80%
uptake
40%
interventions
40%
reimbursement
40%
decision making
40%
cost
40%
laboratories
40%
inclusions
40%
values
40%
incentives
20%
legislation
20%
sustainable development
20%
legal aspects
20%
Keyphrases
COVID-19
80%
Netherlands
80%
Hong Kong
80%
Teleconsultation
80%
Primary Care Setting
80%
Comprehensive Genomic Profiling
80%
Technology Assessment
80%
Advanced Cancer
80%
Diagnostic Results
53%
Diagnostic Pathway
26%
Limited Value
26%
Health Benefits
26%
Five-factor
26%
Evidence Generation
26%
Reimbursement
26%
Outcome Definition
26%
Feasibility Trial
26%
Comparison Strategy
26%
Treatment Pathways
26%
Four-level
22%
Contextual Factors
22%
COVID-19 Pandemic
22%
Health Financing
11%
Political Action
11%
Organizational Level
11%
Legal Framework
11%
Sustainable Development
11%
Primary Care Practitioners
11%
Primary Care Physicians
11%
Open-ended Interviews
11%
